Pharming Group N.V. (PHAR)

NASDAQ: PHAR · Real-Time Price · USD

19.89

+1.97 (10.99%)

Jan 22, 2026, 4:00 PM EST - Market closed

Revenue by Product

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2014 - 2018
Recombinant Human C1 Esterase Inhibitor	226.91M	Log In	Log In	Log In	Log In	Upgrade
Recombinant Human C1 Esterase Inhibitor Growth	15.98%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2014 - 2018
United States	221.17M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	16.17%	Log In	Log In	Log In	Log In	Upgrade
Europe and Rest of World	5.74M	Log In	Log In	Log In	Log In	Upgrade
Europe	-	Log In	Log In	Log In	Log In	Upgrade
Europe Growth	-	Log In	Log In	Log In	Log In	Upgrade
Rest of the World	-	Log In	Log In	Log In	Log In	Upgrade
Rest of the World Growth	-	Log In	Log In	Log In	Log In	Upgrade